Clinical Trials Directory

Trials / Completed

CompletedNCT06349707

Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic

Relevance of the Multiplex PCR Approach for Severe Respiratory Infections of Patients Hospitalized - Including an Intensive Care Unit, During the COVID-19 Pandemic

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge.

Detailed description

The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge: * the main goal was to perform a retrospective investigation of the molecular virological tests in a University hospital, in order to identify non-COVID-19 respiratory viruses from the beginning of 2021 to mid-2022 during the circulation of SARS-CoV-2, for public health knowledge; * the secondary aim was to retrospectively analyze, for a small subgroup of patients from an intensive care unit, the files of patients with positive molecular virological tests for non-COVID-19 respiratory viruses from the beginning of 2021 to mid-2022, reporting the following standard-of-care data: (i) the identification of the viruses, (ii) bioclinical features, (iii) medical impact of virological results in real life.

Conditions

Interventions

TypeNameDescription
OTHERother: ObservationalFor 18 ICU patients, retrospective collection of routine bioclinical database (ICCA db)

Timeline

Start date
2024-04-01
Primary completion
2024-05-01
Completion
2024-06-01
First posted
2024-04-05
Last updated
2025-02-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06349707. Inclusion in this directory is not an endorsement.